TABLE 41.
Country | 2022 | 2021 | 2020 | 2019 | 2018 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Status | National coverage c | Data format c | Confirmed cases and rate | Confirmed cases and rate | Confirmed cases and rate | Confirmed cases and rate | Confirmed cases and rate | |||||||
Bv a |
Ov, Cp b |
Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | |||
Austria | DFS | DFS | Y | C | 7 | 0.08 | 6 | 0.07 | 8 | 0.09 | 6 | 0.07 | 7 | 0.08 |
Belgium | DFS | DFS | Y | C | 3 | 0.03 | 7 | 0.06 | 4 | 0.03 | 3 | 0.03 | 9 | 0.08 |
Bulgaria | Y | A | 2 | 0.03 | 0 | 0 | 1 | 0.01 | 0 | 0 | 1 | 0.01 | ||
Croatia | DFS | Y | C | 2 | 0.05 | 2 | 0.05 | 1 | 0.02 | 3 | 0.07 | 3 | 0.07 | |
Cyprus | DFS | DFS | Y | C | 0 | 0 | 1 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 |
Czechia | DFS | DFS | Y | C | 0 | 0 | 1 | 0.01 | 0 | 0 | 4 | 0.04 | 4 | 0.04 |
Denmark d | DFS | DFS | – | – | – | – | – | – | – | – | – | – | – | – |
Estonia | DFS | DFS | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.08 | 1 | 0.08 |
Finland | DFS | DFS | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
France e | DFS | Y | C | 37 | 0.05 | 21 | 0.03 | 19 | 0.03 | 34 | 0.05 | 26 | 0.04 | |
Germany | DFS | DFS | Y | C | 35 | 0.04 | 13 | 0.02 | 19 | 0.02 | 36 | 0.04 | 37 | 0.04 |
Greece | Y | C | 35 | 0.33 | 24 | 0.22 | 30 | 0.28 | 65 | 0.61 | 97 | 0.90 | ||
Hungary | DFS | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Ireland | DFS | DFS | Y | C | 1 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Italy | Y | C | 20 | 0.03 | 32 | 0.05 | 18 | 0.03 | 49 | 0.08 | 94 | 0.16 | ||
Latvia | DFS | DFS | Y | C | 0 | 0 | 0 | 0 | 1 | 0.05 | 0 | 0 | 0 | 0 |
Lithuania | DFS | DFS | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Luxembourg | DFS | DFS | Y | C | 1 | 0.15 | 1 | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 |
Malta | DFS | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Netherlands | DFS | DFS | Y | C | 5 | 0.03 | 2 | 0.01 | 2 | 0.01 | 7 | 0.04 | 5 | 0.03 |
Poland | DFS | DFS | Y | C | 1 | < 0.01 | 1 | < 0.01 | 0 | 0 | 2 | 0.01 | 0 | 0 |
Portugal | Y | C | 13 | 0.13 | 10 | 0.10 | 9 | 0.09 | 33 | 0.32 | 19 | 0.18 | ||
Romania | DFS | DFS | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0.01 |
Slovakia | DFS | DFS | Y | C | 3 | 0.06 | 6 | 0.11 | 2 | 0.04 | 1 | 0.02 | 0 | 0 |
Slovenia | DFS | DFS | Y | C | 1 | 0.05 | 0 | 0 | 1 | 0.05 | 6 | 0.29 | 3 | 0.15 |
Spain f | DFS | DFS | Y | C | 22 | 0.05 | 25 | – | 10 | – | 20 | 0.04 | 40 | 0.09 |
Sweden | DFS | DFS | Y | C | 10 | 0.10 | 10 | 0.10 | 7 | 0.07 | 14 | 0.14 | 11 | 0.11 |
EU Total 27 | – | – | 198 | 0.04 | 162 | 0.03 | 132 | 0.03 | 285 | 0.06 | 358 | 0.08 | ||
United Kingdom g | – | – | – | – | – | – | – | – | – | – | 24 | 0.04 | – | – |
EU Total | – | – | 198 | 0.04 | 162 | 0.03 | 132 | 0.03 | 309 | 0.06 | 358 | 0.08 | ||
Iceland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Norway | DFS | DFS | Y | C | 1 | 0.02 | 3 | 0.06 | 2 | 0.04 | 4 | 0.08 | 3 | 0.06 |
Liechtenstein | DFS | DFS | Y | C | 0 | 0 | 0 | 0 | 3 | 0.03 | 7 | 0.08 | 5 | 0.06 |
Switzerland h | DFS | DFS | Y | C | 6 | 0.07 | 6 | 0.07 |
Abbreviations: –, Data not reported; DFS, Disease‐free status from infection with B. abortus, B. melitensis and B. suis in bovine animal populations and/or in ovine and caprine animal populations.
Bovine animal populations.
Ovine and caprine animal populations.
Y, yes; N, no; A, aggregated data; C, case‐based data.
No surveillance system.
Metropolitan France obtained disease‐free status in 2022 whereas overseas French regions did not have this status.
Data incomplete for 2020–2021, rate not estimated.
Cases reported by the United Kingdom for the period 2018–2019 were also taken into account for this estimation (EU‐28). Data for the United Kingdom were collected for the 2018–2019 period, since it was still an EU MS at that time. However, on 1 February 2020, it became a third country.
Switzerland provided data directly to EFSA. The human data for Switzerland include data from Liechtenstein for the years 2018–2020.
All zones of the MS have disease‐free status.
Not all zones of the MS have disease‐free status.
No zones of the MS have disease‐free status.